Belvedere Trading’s Cidara Therapeutics CDTX Stock Holding History

Belvedere Trading’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$110K	–	778
2025 Q4	$110K	Sell	500 -100	-17%	-$16.2K	﹤0.01%	565
2025 Q3	$57.5K	Buy	+600	New	+$38.3K	﹤0.01%	661

Belvedere Trading's CDTX Position: Q4 2025 in Review

Belvedere Trading sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 2,635 shares — an estimated $426K sold.

Belvedere Trading first reported a position in CDTX in Q3 2025 and held it in 1 quarter. The position peaked at $252K in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

Belvedere Trading reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
Belvedere Trading sold 2,635 Cidara Therapeutics shares in Q4 2025, an estimated $426K.
Belvedere Trading first reported a position in Cidara Therapeutics in Q3 2025 and held it in 1 quarter.
Belvedere Trading's Cidara Therapeutics position peaked at $252K in Q3 2025.
255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on Belvedere Trading's 13F filing for Q4 2025, filed 10 Feb 2026.